Literature DB >> 16741580

Defective regulatory and effector T cell functions in patients with FOXP3 mutations.

Rosa Bacchetta1, Laura Passerini, Eleonora Gambineri, Minyue Dai, Sarah E Allan, Lucia Perroni, Franca Dagna-Bricarelli, Claudia Sartirana, Susanne Matthes-Martin, Anita Lawitschka, Chiara Azzari, Steven F Ziegler, Megan K Levings, Maria Grazia Roncarolo.   

Abstract

The autoimmune disease immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) is caused by mutations in the forkhead box protein P3 (FOXP3) gene. In the mouse model of FOXP3 deficiency, the lack of CD4+ CD25+ Tregs is responsible for lethal autoimmunity, indicating that FOXP3 is required for the differentiation of this Treg subset. We show that the number and phenotype of CD4+ CD25+ T cells from IPEX patients are comparable to those of normal donors. CD4+ CD25high T cells from IPEX patients who express FOXP3 protein suppressed the in vitro proliferation of effector T cells from normal donors, when activated by "weak" TCR stimuli. In contrast, the suppressive function of CD4+ CD25high T cells from IPEX patients who do not express FOXP3 protein was profoundly impaired. Importantly, CD4+ CD25high T cells from either FOXP3+ or FOXP3- IPEX patients showed altered suppression toward autologous effector T cells. Interestingly, IL-2 and IFN-gamma production by PBMCs from IPEX patients was significantly decreased. These findings indicate that FOXP3 mutations in IPEX patients result in heterogeneous biological abnormalities, leading not necessarily to a lack of differentiation of CD4+ CD25high Tregs but rather to a dysfunction in these cells and in effector T cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16741580      PMCID: PMC1472239          DOI: 10.1172/JCI25112

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  47 in total

1.  De novo generation of antigen-specific CD4+CD25+ regulatory T cells from human CD4+CD25- cells.

Authors:  Mindi R Walker; Bryan D Carson; Gerald T Nepom; Steven F Ziegler; Jane H Buckner
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-07       Impact factor: 11.205

Review 2.  Regulatory T cells.

Authors:  Bruce R Blazar; Patricia A Taylor
Journal:  Biol Blood Marrow Transplant       Date:  2005-02       Impact factor: 5.742

3.  Foxp3 interacts with nuclear factor of activated T cells and NF-kappa B to repress cytokine gene expression and effector functions of T helper cells.

Authors:  Estelle Bettelli; Maryam Dastrange; Mohamed Oukka
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-24       Impact factor: 11.205

4.  How defects in central tolerance impinge on a deficiency in regulatory T cells.

Authors:  Zhibin Chen; Christophe Benoist; Diane Mathis
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-03       Impact factor: 11.205

5.  Cellular and molecular characterization of the scurfy mouse mutant.

Authors:  L B Clark; M W Appleby; M E Brunkow; J E Wilkinson; S F Ziegler; F Ramsdell
Journal:  J Immunol       Date:  1999-03-01       Impact factor: 5.422

Review 6.  FOXP3: of mice and men.

Authors:  Steven F Ziegler
Journal:  Annu Rev Immunol       Date:  2006       Impact factor: 28.527

7.  Analysis of FOXP3 protein expression in human CD4+CD25+ regulatory T cells at the single-cell level.

Authors:  Giovanna Roncador; Philip J Brown; Lorena Maestre; Sophie Hue; Jorge L Martínez-Torrecuadrada; Khoon-Lin Ling; Sarah Pratap; Christy Toms; Bridget C Fox; Vincenzo Cerundolo; Fiona Powrie; Alison H Banham
Journal:  Eur J Immunol       Date:  2005-06       Impact factor: 5.532

8.  The role of 2 FOXP3 isoforms in the generation of human CD4+ Tregs.

Authors:  Sarah E Allan; Laura Passerini; Rosa Bacchetta; Natasha Crellin; Minyue Dai; Paul C Orban; Steven F Ziegler; Maria Grazia Roncarolo; Megan K Levings
Journal:  J Clin Invest       Date:  2005-10-06       Impact factor: 14.808

9.  The Scurfy mutation of FoxP3 in the thymus stroma leads to defective thymopoiesis.

Authors:  Xing Chang; Jian Xin Gao; Qi Jiang; Jing Wen; Nick Seifers; Lishan Su; Virginia L Godfrey; Tao Zuo; Pan Zheng; Yang Liu
Journal:  J Exp Med       Date:  2005-10-17       Impact factor: 14.307

10.  IFN-gamma production by alloantigen-reactive regulatory T cells is important for their regulatory function in vivo.

Authors:  Birgit Sawitzki; Cherry I Kingsley; Vanessa Oliveira; Mahzuz Karim; Manuela Herber; Kathryn J Wood
Journal:  J Exp Med       Date:  2005-06-20       Impact factor: 14.307

View more
  173 in total

Review 1.  Mechanisms of inflammatory responses in obese adipose tissue.

Authors:  Shengyi Sun; Yewei Ji; Sander Kersten; Ling Qi
Journal:  Annu Rev Nutr       Date:  2012-03-09       Impact factor: 11.848

Review 2.  Learning to live together: harnessing regulatory T cells to induce organ transplant tolerance.

Authors:  Andrew Y Chang; Nupur Bhattacharya
Journal:  Yale J Biol Med       Date:  2011-12

Review 3.  Regulatory T-cell therapy for inflammatory bowel disease: more questions than answers.

Authors:  Megan E Himmel; Yu Yao; Paul C Orban; Theodore S Steiner; Megan K Levings
Journal:  Immunology       Date:  2012-06       Impact factor: 7.397

4.  Tregs and human atherothrombotic diseases: toward a clinical application?

Authors:  Giuseppina Caligiuri; Antonino Nicoletti
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-09       Impact factor: 8.311

Review 5.  Genetics, pathogenesis and clinical interventions in type 1 diabetes.

Authors:  Jeffrey A Bluestone; Kevan Herold; George Eisenbarth
Journal:  Nature       Date:  2010-04-29       Impact factor: 49.962

6.  FOXP3, CBLB and ITCH gene expression and cytotoxic T lymphocyte antigen 4 expression on CD4(+) CD25(high) T cells in multiple sclerosis.

Authors:  F Sellebjerg; M Krakauer; M Khademi; T Olsson; P S Sørensen
Journal:  Clin Exp Immunol       Date:  2012-11       Impact factor: 4.330

7.  The role of the CD58 locus in multiple sclerosis.

Authors:  Philip L De Jager; Clare Baecher-Allan; Lisa M Maier; Ariel T Arthur; Linda Ottoboni; Lisa Barcellos; Jacob L McCauley; Stephen Sawcer; An Goris; Janna Saarela; Roman Yelensky; Alkes Price; Virpi Leppa; Nick Patterson; Paul I W de Bakker; Dong Tran; Cristin Aubin; Susan Pobywajlo; Elizabeth Rossin; Xinli Hu; Charles W Ashley; Edwin Choy; John D Rioux; Margaret A Pericak-Vance; Adrian Ivinson; David R Booth; Graeme J Stewart; Aarno Palotie; Leena Peltonen; Bénédicte Dubois; Jonathan L Haines; Howard L Weiner; Alastair Compston; Stephen L Hauser; Mark J Daly; David Reich; Jorge R Oksenberg; David A Hafler
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-23       Impact factor: 11.205

8.  Adipose-Derived Stem Cells Ameliorate Experimental Murine Colitis via TSP-1-Dependent Activation of Latent TGF-β.

Authors:  Hiroshi Takeyama; Tsunekazu Mizushima; Mamoru Uemura; Naotsugu Haraguchi; Junichi Nishimura; Taishi Hata; Chu Matsuda; Ichiro Takemasa; Masakazu Ikenaga; Kohei Murata; Hirofumi Yamamoto; Yuichiro Doki; Masaki Mori
Journal:  Dig Dis Sci       Date:  2017-04-22       Impact factor: 3.199

Review 9.  Breakdown of T cell tolerance and autoimmunity in primary immunodeficiency--lessons learned from monogenic disorders in mice and men.

Authors:  Lisa S Westerberg; Christoph Klein; Scott B Snapper
Journal:  Curr Opin Immunol       Date:  2008-11-12       Impact factor: 7.486

10.  Regulatory T cells in type 1 diabetic patients with autoimmune chronic atrophic gastritis.

Authors:  Núria Alonso; María Jesús Martínez-Arconada; María Luisa Granada; Berta Soldevila; Ana Cantón; José Luis Mate; Anna Sanmartí; Eva María Martínez-Cáceres
Journal:  Endocrine       Date:  2009-03-17       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.